The urea breath test is a non-invasive diagnostic test used to detect the presence of Helicobacter pylori (H. pylori) bacteria in the stomach and duodenum. It involves administration of urea labelled with carbon-13 or carbon-14 isotope and subsequent measurement of carbon dioxide in the breath.

The global urea breath test market size is projected to be valued at US$ 140.8 Mn in 2023due to the increasing burden of H. pylori infection worldwide. The global urea breath test market is estimated to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031.

Market key trends:
One of the key market trends driving the growth of the urea breath test market is the rising prevalence of H. pylori infection globally. H. pylori infection is considered as one of the major risk factors for peptic ulcer disease and gastric cancer. According to the WHO, over 50% of the world's population suffers from H. pylori infection. The rising cases of H. pylori infection, especially in developing countries has augmented the demand for effective diagnostic tests for detection of the infection. The urea breath test has gained significance as a reliable, non-invasive diagnostic method with high sensitivity and specificity for H. pylori detection. Improved accuracy and reduced procedure time of urea breath tests compared to invasive endoscopic procedures such as gastric biopsy has further boosted their adoption in clinical practice.

Segment Analysis
The global urea breath test market is dominated by the Hydrogen Ureabreath Test sub segment due to its simplicity, non-invasive nature, and suitability for both adult and pediatric population. The hydrogen ureabreath test evaluates the presence of the bacterium Helicobacter pylori (H. pylori) in the digestive system by measuring the amount of radioactive carbon dioxide (CO2) or hydrogen (H2) in exhaled breath. It is considered the gold standard for detecting H. pylori infection in individuals.

Key Takeaways
The Global Urea Breath Test Market Size is expected to witness high growth during the forecast period of 2024 to 2031. The global Urea Breath Test Market is estimated to be valued at US$ 140.8 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031.

Regional analysis: North America region currently dominates the global market due to high prevalence of H. pylori infection and favorable reimbursement policies for diagnostic procedures in the region. However, the Asia Pacific region is expected to grow at the fastest pace during the forecast period owing rising awareness regarding early diagnosis of gastric diseases and increasing healthcare expenditure in emerging countries of China and India.

Key players: Key players operating in the urea breath test market are Al Dahra ACX Global Inc., Alfalfa Monegros SL, Anderson Hay & Grain Inc., Bailey Farms, Border Valley, Coaba, Cubeit Hay Company, Glenvar Hay, Green Prairie International, Grupo Osés, Gruppo Carli, Hay USA, Haykingdom Inc., Oregon Hay Products, Inc., Los Venteros SC, M&C Hay, Legal Alfalfa Products Ltd., Riverina (Australia) Pty Ltd, SL Follen Company, and Standlee Hay Company. Major players are focusing on new product launches and mergers & acquisitions to strengthen their market position and expand their global presence.


Get more insights on this topic:

Check below trending articles on this topic: